Literature DB >> 6712142

Determination of caffeine, theophylline and theobromine in serum and saliva using high-performance liquid chromatography.

N R Scott, J Chakraborty, V Marks.   

Abstract

A method is described for the measurement of theobromine, theophylline and caffeine in serum and saliva by high-performance liquid chromatography (HPLC). A chloroform/isopropanol extract (85:15, v/v) is evaporated to dryness and chromatographed on a 100 X 4.5 mm id Hypersil octadecylsilane column with UV detection at 280 nm. Theobromine, theophylline, caffeine and the internal standard proxyphylline are satisfactorily resolved with an elution system of acetonitrile/tetrahydrofuran/50 mM acetate buffer, pH 4.0, (4:1:95, v/v). No interference is observed from the presence of xanthine metabolites or any of a number of common drugs examined. A good correlation was observed between the concentrations of caffeine in serum and in saliva suggesting that salivary measurements may be useful for the study of caffeine pharmacokinetics in man. Caffeine levels determined by the HPLC procedure described here agreed well with those obtained by a radioimmunoassay method. The method is also suitable for determining the xanthine content of beverages by direct injection of diluted samples.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712142     DOI: 10.1177/000456328402100208

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  6 in total

1.  Caffeine and blood pressure response: sex, age, and hormonal status.

Authors:  Noha H Farag; Thomas L Whitsett; Barbara S McKey; Michael F Wilson; Andrea S Vincent; Susan A Everson-Rose; William R Lovallo
Journal:  J Womens Health (Larchmt)       Date:  2010-06       Impact factor: 2.681

2.  Sex differences in the hemodynamic responses to mental stress: Effect of caffeine consumption.

Authors:  Noha H Farag; Andrea S Vincent; Barbara S McKey; Mustafa Al'Absi; Thomas L Whitsett; William R Lovallo
Journal:  Psychophysiology       Date:  2006-07       Impact factor: 4.016

3.  Self-report reliability and symptomatology of habitual caffeine consumption.

Authors:  J E James; M S Bruce; M H Lader; N R Scott
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

4.  The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

Authors:  N R Scott; D Stambuk; J Chakraborty; V Marks; M Y Morgan
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

5.  The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects.

Authors:  M Bruce; N Scott; M Lader; V Marks
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 6.  Pharmacokinetics of Caffeine: A Systematic Analysis of Reported Data for Application in Metabolic Phenotyping and Liver Function Testing.

Authors:  Jan Grzegorzewski; Florian Bartsch; Adrian Köller; Matthias König
Journal:  Front Pharmacol       Date:  2022-02-25       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.